The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome.

被引：0
|
作者：
Diz-Kucukkaya, R
Inanc, M
Pekcelen, Y
机构：
[1] Istanbul Univ, Fac Med, Div Hematol, Dept Internal Med, Istanbul, Turkey
[2] Istanbul Univ, Fac Med, Div Rheumatol, Dept Internal Med, Istanbul, Turkey
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.4050.4050
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4050
引用
收藏
页码：99B / 99B
页数：1
相关论文
共 50 条
  • [21] Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome:: prevalence and clinical significance in 667 patients
    Ramos-Casals, M
    Campoamor, MT
    Chamorro, A
    Salvador, G
    Segura, S
    Botero, JC
    Yagüe, J
    Cervera, R
    Ingelmo, M
    Font, J
    LUPUS, 2004, 13 (10) : 777 - 783
  • [22] ANTIPHOSPHOLIPID ANTIBODIES IN LUPUS PATIENTS WITH SEIZURES: PREVALENCE AND CLINICAL SIGNIFICANCE
    Sanna, G.
    Bertolaccini, M. L.
    Cuadrado, M. J.
    Khamashta, M. A.
    Hughes, G. R. V.
    RHEUMATOLOGY, 2003, 42 : 79 - 79
  • [23] Prevalence and clinical significance of antiphospholipid antibodies in patients with scleroderma.
    Bertolaccini, ML
    Sanna, G
    Mameli, A
    Khamashta, MA
    Mathieu, A
    Hughes, GRV
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S147 - S147
  • [24] Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?
    Berman, H.
    Ugarte-Gil, M. F.
    Espinosa, G.
    Tassies, D.
    Monteagudo, J.
    Reverter, J. C.
    Cervera, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (06) : 926 - 932
  • [25] Predictive factors and prevention of catastrophic antiphospholipid syndrome.
    Rodriguez, JR
    Carrasco, MG
    Deleze, M
    Coronel, GE
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1623 - 1623
  • [26] Acquired and inherited thrombophilic factors and the risk for residual venous thrombosis
    Bank, I
    Tick, LW
    Hutten, BA
    Kramer, MHH
    Middeldorp, S
    Büller, HR
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 (04) : 192 - 196
  • [27] Antiphospholipid antibodies and the antiphospholipid syndrome: Clinical significance and treatment
    Asherson, Ronald A.
    Cervera, Ricard
    Merrill, Joan T.
    Erkan, Doruk
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2008, 34 (03): : 256 - 266
  • [28] Thrombophilic factors in patients with syndrome X
    Terpos, E
    Athanasiou, A
    THROMBOSIS RESEARCH, 2000, 97 (06) : 525 - 527
  • [29] Prevalence and clinical significance of Antiphospholipid antibodies in lupus patients with seizures.
    Sanna, G
    Bertolaccini, ML
    Cuadrado, MJ
    Khamashta, MA
    Hughes, GRV
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S49 - S49
  • [30] Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome
    del-Pino, Rodrigo Aguirre
    Monahan, Rory C.
    Huizinga, Tom W. J.
    Eikenboom, Jeroen
    Steup-Beekman, Gerda M.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2024, 50 (06): : 817 - 828
12345